Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Cell Reports|May 15, 2026
TP53-based tripartite classification reveals three distinct mutation patterns across pan-cancerFayang Ma, Zigang DongNature Communications|September 27, 2022
The comparison of cancer gene mutation frequencies in Chinese and U.S. patient populationsFayang Ma, Kyle Laster, Zigang DongCritical Reviews in Immunology|April 26, 2021
COVID-19 and Strategies for Its TherapeuticsFayang Ma, Tingxuan Gu, Simin Zhao, et al.International Journal of Nursing Practice|February 20, 2018
Testing the validity and reliability of the Self-Administration of Medication (SAM) instrument in Chinese chronic disease patients: A cross-cultural adaptationBeilei Lin, Yongxia Mei, Fayang Ma, et al.BMJ Open|June 24, 2019
Unmet care needs of community-dwelling stroke survivors: a protocol for systematic review and theme analysis of quantitative and qualitative studiesBeilei Lin, Chunge Ding, Yongxia Mei, et al.Molecular Cancer|October 6, 2022
Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancerXueli Tian, Rui Wang, Tingxuan Gu, et al.Phytotherapy Research : PTR|December 12, 2018
Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2Li Wang, Xiangyu Wang, Hanyong Chen, et al.Cellular Oncology (Dordrecht, Netherlands)|February 1, 2022
Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinomaXiangyu Wang, Xiaomeng Xie, Yuanyuan Zhang, et al.Journal of Cancer|June 7, 2021
Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived XenograftsFayang Ma, Kyle Laster, Wenna Nie, et al.Journal of Cancer|June 17, 2022
3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle in Esophageal Squamous Cell Carcinoma <i>in vivo</i>Fayang Ma, Fangfang Liu, Wenna Nie, et al.Pageof 2